Deceased donor kidney allocation schemes and international exchange

dc.authoridGokalp, Cenk/0000-0003-3909-7973
dc.authorwosidSprangers, Ben/T-6559-2017
dc.authorwosidGokalp, Cenk/AGW-1853-2022
dc.contributor.authorHeemann, Uwe
dc.contributor.authorOberbauer, Rainer
dc.contributor.authorSprangers, Ben
dc.contributor.authorGokalp, Cenk
dc.contributor.authorBemelman, Frederike
dc.date.accessioned2024-06-12T10:50:57Z
dc.date.available2024-06-12T10:50:57Z
dc.date.issued2020
dc.departmentTrakya Üniversitesien_US
dc.description.abstractPurpose of review In this review, we summarize different allocation schemes around the world and identify ways to exchange organs between countries. Recent findings The primary goal of transplantation is prolongation of patient survival and an improved quality of life. Most allocation systems try to match the potential survival of the organ with the life expectancy of its recipient. Kidney transplantation enables cost reductions by the avoidance of dialysis for the healthcare system, which is sometimes the driving force for state interventions to enhance donor recruitment The major benefit from international exchange is the possibility to transplant highly sensitized patients or patients with rare HLA allele. In a broad international exchange system, there are three possibilities: exchange of surplus organs, exchange of organs to support patients with a potentially excessive waiting time because of HLA antibodies or rare alleles, and exchange of organs to make the best possible match between donor and recipient. It is possible to shape a hierarchical allocation scheme, which could be applicable in the majority of populations despite different geographical and socioeconomic conditions: allocation to recipients with special requirements (high-urgency, highly sensitized); identification of a within the region/country; in case no suitable recipient can be identified, offer countrywide or between countries; for every organ transferred to another country, there must be an obligation to give one back.en_US
dc.identifier.doi10.1097/MOT.0000000000000720
dc.identifier.endpage73en_US
dc.identifier.issn1087-2418
dc.identifier.issn1531-7013
dc.identifier.issue1en_US
dc.identifier.pmid31815789en_US
dc.identifier.scopus2-s2.0-85077221903en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage66en_US
dc.identifier.urihttps://doi.org/10.1097/MOT.0000000000000720
dc.identifier.urihttps://hdl.handle.net/20.500.14551/18185
dc.identifier.volume25en_US
dc.identifier.wosWOS:000563512200011en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofCurrent Opinion In Organ Transplantationen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAgeen_US
dc.subjectAllocationen_US
dc.subjectIschemiaen_US
dc.subjectKidney Transplantationen_US
dc.subjectWaiting Listen_US
dc.subjectGraft Failureen_US
dc.subjectUrgency Priorityen_US
dc.subjectUnited-Statesen_US
dc.subjectHla Mismatchen_US
dc.subjectWaiting Timeen_US
dc.subjectTransplantationen_US
dc.subjectOutcomesen_US
dc.subjectRisken_US
dc.subjectMortalityen_US
dc.subjectDialysisen_US
dc.titleDeceased donor kidney allocation schemes and international exchangeen_US
dc.typeReview Articleen_US

Dosyalar